487 related articles for article (PubMed ID: 6321840)
1. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
Stutman O
Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
5. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
Blair PB; Lane MA; Yagi MJ
J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
[TBL] [Abstract][Full Text] [Related]
6. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
Blair PB; Lane MA
J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
[TBL] [Abstract][Full Text] [Related]
7. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
Blair PB; Lane MA; Mar P
J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
Tagliabue A; Herberman RB; McCoy JL
Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
[No Abstract] [Full Text] [Related]
9. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
Lavrovsky VA; Viksler VK
Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
[TBL] [Abstract][Full Text] [Related]
11. The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system.
Creemers P
Eur J Immunol; 1977 Jan; 7(1):48-53. PubMed ID: 191259
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cellular immune response to cancer of the breast.
Herberman RB
Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
[TBL] [Abstract][Full Text] [Related]
13. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
Gillette RW; Lowery LT
Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922
[TBL] [Abstract][Full Text] [Related]
14. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
Black MM; Zachrau RE
J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
Yagi MJ
Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
[TBL] [Abstract][Full Text] [Related]
16. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
17. In vitro immune responses to viral and tumor antigens in murine breast cancer.
Sigel MM; Lopez DM; Ortiz-Muniz G
Cancer Res; 1976 Feb; 36(2 pt 2):748-52. PubMed ID: 1253159
[TBL] [Abstract][Full Text] [Related]
18. Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens.
Bowen JM; Dmochowski L; Miller MF; Priori ES; Seman G; Dodson ML; Maruyama K
Cancer Res; 1976 Feb; 36(2 pt 2):759-64. PubMed ID: 175935
[TBL] [Abstract][Full Text] [Related]
19. Natural immunity in the oncornavirus-infected mouse.
Blair PB
Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
